| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Mar-26 | 192.09 | 77.48 | 76.15p | 6.3 | 0.7 | +9% | 58.38p | 0.0% |
| 31-Mar-27 | 199.45 | 79.63 | 83.20p | 5.7 | 0.6 | +9% | 42.20p | 0.0% |
| 31-Mar-28 | 204.51 | 80.81 | 93.70p | 5.1 | 0.4 | +13% | 42.27p | 0.0% |
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
| Year Ending | Revenue/Share | Price/Revenue per Share |
|---|---|---|
| 31-Mar-26 | £2.82 | 1.69 |
| 31-Mar-27 | £2.93 | 1.63 |
| 31-Mar-28 | £3.00 | 1.59 |
| Current | 1 week ago | 1 month ago | 3 months ago | 6 months ago | 1 year ago | |
|---|---|---|---|---|---|---|
| Revenue (£m) | ||||||
| 31-Mar-2026 | 192 | n/a | n/a | n/a | n/a | 202 |
| 31-Mar-2027 | 200 | n/a | n/a | n/a | n/a | 216 |
| 31-Mar-2028 | 204 | n/a | n/a | n/a | n/a | n/a |
| Earnings | ||||||
| 31-Mar-2026 | 76.15p | n/a | n/a | n/a | n/a | 77.06p |
| 31-Mar-2027 | 83.20p | n/a | n/a | n/a | n/a | 89.79p |
| 31-Mar-2028 | 93.70p | n/a | n/a | n/a | n/a | n/a |
| Dividend | ||||||
| 31-Mar-2026 | 58.38p | n/a | n/a | n/a | n/a | 39.91p |
| 31-Mar-2027 | 42.20p | n/a | n/a | n/a | n/a | 40.71p |
| 31-Mar-2028 | 42.27p | n/a | n/a | n/a | n/a | n/a |
| Recommendations | ||||||
| Strong Buy | 2 | 2 | 2 | 0 | 0 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Neutral | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 0 | 0 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Brokers | 3 | 3 | 3 | 0 | 0 | 4 |
| Average Rec | 7.50 | 7.50 | 7.50 | n/a | n/a | 8.12 |
| Currency | UK Pounds |
| Share Price | 474.50p |
| Change Today | -2.50p |
| % Change | -0.52 % |
| 52 Week High | 855.00 |
| 52 Week Low | 441.50 |
| Volume | 1,592 |
| Shares Issued | 68.09m |
| Market Cap | £323.08m |
| Strong Buy | 2 |
| Buy | 0 |
| Neutral | 0 |
| Sell | 1 |
| Strong Sell | 0 |
| Total | 3 |

| Time | Volume / Share Price |
| 10:45 | 183 @ 474.50p |
| 10:45 | 124 @ 474.50p |
| 10:32 | 195 @ 474.00p |
| 10:32 | 261 @ 474.00p |
| 10:29 | 136 @ 472.50p |
| CEO | Nick Wiles |
| Chair | Giles Kerr |
| CFO | Rob Harding |
You are here: research